Tanaka F - Search Results

1

D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.

Iwakiri S, Nagai S, Katakura H, Takenaka K, Date H, Wada H, Tanaka F. Iwakiri S, et al. Among authors: tanaka f. Ann Surg Oncol. 2009 Jun;16(6):1678-85. doi: 10.1245/s10434-009-0432-6. Epub 2009 Mar 28. Ann Surg Oncol. 2009. PMID: 19330380

2

Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung.

Nakagawa T, Tanaka F, Otake Y, Yanagihara K, Miyahara R, Matsuoka K, Takata T, Yamada T, Fukushima M, Wada H. Nakagawa T, et al. Among authors: tanaka f. Lung Cancer. 2002 Feb;35(2):165-70. doi: 10.1016/s0169-5002(01)00407-x. Lung Cancer. 2002. PMID: 11804689

3

A pitfall of CT findings in peripheral lung adenocarcinoma.

Morimoto K, Miyahara R, Li M, Yanagihara K, Tanaka F, Togashi K, Ito H, Wada H. Morimoto K, et al. Among authors: tanaka f. J Comput Assist Tomogr. 2002 Mar-Apr;26(2):197-8. doi: 10.1097/00004728-200203000-00006. J Comput Assist Tomogr. 2002. PMID: 11884773 No abstract available.

4

Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion.

Shoji T, Tanaka F, Yanagihara K, Inui K, Wada H. Shoji T, et al. Among authors: tanaka f. Chest. 2002 Mar;121(3):821-4. doi: 10.1378/chest.121.3.821. Chest. 2002. PMID: 11888966 Clinical Trial.

5

Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer.

Tanaka F, Takata T, Yamada T, Yanagihara K, Otake Y, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Inui K, Wada H. Tanaka F, et al. Lung Cancer. 2002 Apr;36(1):27-32. doi: 10.1016/s0169-5002(01)00462-7. Lung Cancer. 2002. PMID: 11891030

6

Treatment of necrotic infection on the anterior chest wall secondary to mastectomy and postoperative radiotherapy by the application of omentum and mesh skin grafting: report of a case.

Sato M, Tanaka F, Wada H. Sato M, et al. Among authors: tanaka f. Surg Today. 2002;32(3):261-3. doi: 10.1007/s005950200031. Surg Today. 2002. PMID: 11991513

7

Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer.

Katakura H, Tanaka F, Oyanagi H, Miyahara R, Yanagihara K, Otake Y, Wada H. Katakura H, et al. Among authors: tanaka f. Ann Thorac Surg. 2002 Apr;73(4):1060-4. doi: 10.1016/s0003-4975(01)03597-4. Ann Thorac Surg. 2002. PMID: 11996241

8

Clinical significance of p21 expression in non-small-cell lung cancer.

Shoji T, Tanaka F, Takata T, Yanagihara K, Otake Y, Hanaoka N, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Katakura H, Wada H. Shoji T, et al. Among authors: tanaka f. J Clin Oncol. 2002 Sep 15;20(18):3865-71. doi: 10.1200/JCO.2002.09.147. J Clin Oncol. 2002. PMID: 12228206

9

Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.

Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H. Nakagawa T, et al. Among authors: tanaka f. J Surg Oncol. 2002 Oct;81(2):87-92. doi: 10.1002/jso.10137. J Surg Oncol. 2002. PMID: 12355409

10

Primary lung carcinoma arising from emphysematous bullae.

Hanaoka N, Tanaka F, Otake Y, Yanagihara K, Nakagawa T, Kawano Y, Miyahara R, Li M, Wada H. Hanaoka N, et al. Among authors: tanaka f. Lung Cancer. 2002 Nov;38(2):185-91. doi: 10.1016/s0169-5002(02)00186-1. Lung Cancer. 2002. PMID: 12399131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,660 results

Search Page